2.13
price up icon12.70%   0.24
pre-market  プレマーケット:  2.14   0.01   +0.47%
loading
前日終値:
$1.89
開ける:
$1.92
24時間の取引高:
206.38K
Relative Volume:
1.07
時価総額:
$7.33M
収益:
$895.50K
当期純損益:
$-26.30M
株価収益率:
-1.2988
EPS:
-1.64
ネットキャッシュフロー:
$-23.84M
1週間 パフォーマンス:
+15.14%
1か月 パフォーマンス:
+48.95%
6か月 パフォーマンス:
-56.53%
1年 パフォーマンス:
-84.74%
1日の値動き範囲:
Value
$1.92
$2.17
1週間の範囲:
Value
$1.6201
$2.17
52週間の値動き範囲:
Value
$1.3381
$19.00

Mainz Biomed N V Stock (MYNZ) Company Profile

Name
名前
Mainz Biomed N V
Name
セクター
Healthcare (1161)
Name
電話
-
Name
住所
-
Name
職員
26
Name
Twitter
Name
次回の収益日
2025-05-02
Name
最新のSEC提出書
Name
MYNZ's Discussions on Twitter

MYNZ を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Diagnostics & Research icon
MYNZ
Mainz Biomed N V
2.13 7.06M 895.50K -26.30M -23.84M -1.64
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
404.94 160.56B 42.90B 6.52B 6.72B 17.05
Diagnostics & Research icon
DHR
Danaher Corp
188.07 141.52B 23.82B 3.77B 4.90B 5.15
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
520.87 42.74B 3.93B 894.97M 837.70M 10.82
Diagnostics & Research icon
A
Agilent Technologies Inc
112.04 34.11B 6.63B 1.17B 1.19B 4.05
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
158.96 27.70B 15.50B 1.33B 2.16B 7.34

Mainz Biomed N V Stock (MYNZ) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-02-14 開始されました Maxim Group Buy
2024-11-25 ダウングレード H.C. Wainwright Buy → Neutral
2023-11-21 ダウングレード Cantor Fitzgerald Overweight → Neutral
2022-06-21 開始されました H.C. Wainwright Buy

Mainz Biomed N V (MYNZ) 最新ニュース

pulisher
06:44 AM

Is Mainz Biomed N.V. a good long term investmentRapid growth trajectories - jammulinksnews.com

06:44 AM
pulisher
Jul 21, 2025

What analysts say about Mainz Biomed N.V. stockTremendous financial leverage - Autocar Professional

Jul 21, 2025
pulisher
Jul 21, 2025

Mainz Biomed N.V. Stock Analysis and ForecastBreakthrough profits - Autocar Professional

Jul 21, 2025
pulisher
Jul 20, 2025

What drives Mainz Biomed N.V. stock priceRapid profit acceleration - Autocar Professional

Jul 20, 2025
pulisher
Jul 20, 2025

Why Mainz Biomed N.V. stock attracts strong analyst attentionFree Long-Term Wealth Growth Plan - beatles.ru

Jul 20, 2025
pulisher
Jul 16, 2025

Mainz Biomed (NASDAQ:MYNZ) Trading Up 7% – Here’s Why - Defense World

Jul 16, 2025
pulisher
Jul 16, 2025

Mainz Biomed Half Year 2025 Update: Accelerating FDA - GlobeNewswire

Jul 16, 2025
pulisher
Jul 15, 2025

What makes Mainz Biomed N.V. stock price move sharplyFree Stock Market Expert Consultation - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How Mainz Biomed N.V. stock performs during market volatilityFree Step-by-Step Investment Guide - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Mainz Biomed reviews accomplishments for first half of 2025 - TipRanks

Jul 15, 2025
pulisher
Jul 15, 2025

Mainz Biomed N.V. Announces Key Achievements and Corporate Update for First Half of 2025 - Nasdaq

Jul 15, 2025
pulisher
Jul 15, 2025

Mainz Biomed's Dual Breakthrough: FDA Trial Progress and Revolutionary 95% Accurate Pancreatic Cancer Detection - Stock Titan

Jul 15, 2025
pulisher
Jun 25, 2025

Mainz Biomed (MYNZ) Secures State Funding for Pancreatic Cancer Project | MYNZ Stock News - GuruFocus

Jun 25, 2025
pulisher
Jun 25, 2025

Mainz Biomed Secures Public Funding to Advance Innovative Pancreatic Cancer Screening Test - FinancialContent

Jun 25, 2025
pulisher
Jun 24, 2025

Mainz Biomed (MYNZ) to Release Quarterly Earnings on Tuesday - Defense World

Jun 24, 2025
pulisher
Jun 21, 2025

Where are the Opportunities in (MYNZ) - news.stocktradersdaily.com

Jun 21, 2025
pulisher
Jun 12, 2025

Mainz Biomed (NASDAQ:MYNZ) Trading Down 1.9% – Here’s What Happened - Defense World

Jun 12, 2025
pulisher
Jun 11, 2025

(MYNZ) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com

Jun 11, 2025
pulisher
Jun 10, 2025

Mainz Biomed (MYNZ) Advances PancAlert Project for Pancreatic Ca - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

Mainz Biomed Initiates Feasibility Study Of PancAlert Blood Test For Pancreatic Cancer Detection - Nasdaq

Jun 10, 2025
pulisher
Jun 10, 2025

Mainz Biomed Initiates Feasibility Study Of Biomarker Panel In Pancreatic Cancer Project - MarketScreener

Jun 10, 2025
pulisher
Jun 10, 2025

Mainz Biomed (MYNZ) Advances PancAlert Project for Pancreatic Cancer Detection | MYNZ Stock News - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

Mainz Biomed Initiates Feasibility Phase for Non-Invasive Pancreatic Cancer Screening Test in PancAlert Project - Nasdaq

Jun 10, 2025
pulisher
Jun 10, 2025

Mainz initiates feasibility study of biomarker panel in PancAlert project - TipRanks

Jun 10, 2025
pulisher
Jun 10, 2025

Mainz Biomed Initiates Feasibility Study of Biomarker Panel in Pancreatic Cancer Project - The Manila Times

Jun 10, 2025
pulisher
Jun 05, 2025

Mainz Biomed N.V. Shareholders Approve Key Proposals at Annual Meeting - TipRanks

Jun 05, 2025
pulisher
May 22, 2025

Maxim Group to Act as Sole Placement Agent for MYNZ Offering | M - GuruFocus

May 22, 2025
pulisher
May 21, 2025

Mainz Biomed N.V. Secures $4 Million Through Securities Offering - TipRanks

May 21, 2025
pulisher
May 21, 2025

Mainz Biomed (NASDAQ:MYNZ) Trading Up 5.4% – What’s Next? - Defense World

May 21, 2025
pulisher
May 20, 2025

Mainz Biomed (MYNZ) Prices $4M Follow-On Offering - GuruFocus

May 20, 2025
pulisher
May 20, 2025

Mainz Biomed Announces Pricing of $4.0 Million Follow-On Offering of Ordinary Shares and Warrants - The Manila Times

May 20, 2025
pulisher
May 19, 2025

Maxim Group to Act as Sole Placement Agent for MYNZ Offering | MYNZ Stock News - GuruFocus

May 19, 2025
pulisher
May 19, 2025

Mainz Biomed Announces Pricing of $4 Million Follow-On Offering and Warrant Amendments - Nasdaq

May 19, 2025
pulisher
May 19, 2025

Cancer Detection Company Mainz Biomed Raises Fresh $4M: Key Details of Share and Warrant Offering - Stock Titan

May 19, 2025

Mainz Biomed N V (MYNZ) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
diagnostics_research WAT
$281.66
price down icon 2.04%
diagnostics_research DGX
$166.45
price down icon 0.28%
$140.63
price up icon 1.25%
diagnostics_research LH
$243.04
price down icon 0.28%
diagnostics_research MTD
$1,166.48
price down icon 2.37%
diagnostics_research IQV
$158.96
price down icon 1.04%
大文字化:     |  ボリューム (24 時間):